Peripheral T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Peripheral T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma) [NA]
A clinical trial investigating chidamide in combination with CHOP for newly diagnosed peripheral T cell lymphoma; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
Update on a completed clinical trial evaluating biomarkers in tumor tissue from patients with Peripheral T-cell lymphoma or natural killer c…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy [Phase 4]
Clinical trial update describing a Phase 4 study of pralatrexate in Asian patients with peripheral T-cell lymphoma after prior therapy.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Phase I/II Clinical Study of Forodesine in Japanese Recurrent/Refractory Peripheral T-cell Lymphoma Patients [Phase 1, Phase 2]
This document reports the completion of a Phase I/II clinical study evaluating forodesine in Japanese patients with recurrent or refractory …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial of oral clofarabine in relapsed/refractory non-Hodgkin lymphoma completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Phase 2 Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
A Phase 2 study evaluating total skin electron beam therapy (12 Gy) for stage IB-IIIA mycosis fungoides has been terminated, with results po…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Study of KW-0761 in Subjects With CCR4-positive Peripheral T/NK-cell Lymphoma [Phase 2]
Phase 2 trial of mogamulizumab (KW-0761) for CCR4-positive Peripheral T/NK-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas [Phase 1]
Phase 1 study evaluating CHOP chemotherapy plus Campath-1H (alemtuzumab) as initial treatment for untreated aggressive T/NK-cell non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Pilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30 [NA]
A pilot study of Brentuximab Vedotin in relapsed/refractory CD30-positive Peripheral T-Cell Lymphoma was terminated, with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients [Phase 3]
Phase 3 clinical trial update comparing the CDOP chemotherapy regimen alone versus CDOP combined with chidamide in de novo Peripheral T-Cell…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Treatment of Peripheral T-cell Lymphoma [Phase 4]
Phase 4 clinical trial update on the treatment of Peripheral T-cell Lymphoma. The study has completed and results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL) [Phase 1, Phase 2]
The document reports the completion of a Phase 1/2 trial evaluating romidepsin for peripheral T-cell lymphoma, including efficacy, safety, a…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating chidamide in combination with ICE chemotherapy for relapsed/refractory peripheral T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial sponsored by the National Cancer Institute evaluated alisertib for relapsed or refractory peripheral T-cell non-Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma [Phase 2]
A Phase 2 study evaluated depsipeptide (romidepsin) for cutaneous T-cell lymphoma and peripheral T-cell lymphoma. The trial has completed wi…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update for MORAb-004 in young patients with recurrent or refractory solid tumors or lymphoma; the study has been completed.
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating sorafenib tosylate in patients with recurrent aggressive non-Hodgkin lymphomas has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) [Phase 1]
Completed Phase 1 study evaluating SP-02L in patients with relapsed or refractory Peripheral T-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 study evaluating the combination of methoxyamine and fludarabine phosphate in adults with relapsed or refractory hematologic maligna…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 clinical trial evaluating alemtuzumab with CHOP chemotherapy in patients with aggressive…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated everolimus (RAD001) in combination with CHOP chemotherapy for newly diagnosed peripheral T-cell lymphom…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Cohort of Peripheral T Cell Lymphoma
Clinical trial update for a peripheral T-cell lymphoma cohort with an unknown current status.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma [Phase 2]
Phase 2 pilot study evaluating safety of combining Ontak (denileukin diftitox) with CHOP in Peripheral T-cell lymphoma. Results have been po…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas [Phase 2]
A Phase II study of PXD101 (belinostat) in recurrent or refractory cutaneous T-cell lymphoma and peripheral T-cell lymphoma was terminated; …
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea [Phase 1]
A Phase 1 study evaluating SP-02L in relapsed or refractory peripheral T-cell lymphoma in Korea has completed.